Revelio Appero Designio
Revelio   Appero   Designio
Independent R&D Startup — Pre-Deployment — Seeking Investment & Collaboration

One outcome.
The evidence standard
every regulated decision requires.

Knowledge-based causal intelligence. Customisable by ontology. Built where standard AI structurally fails.

Real-world evidence is not a healthcare concept. It is the compliance substrate every regulated industry runs on — and that no statistical AI architecture can produce. ONE.RING operates on the knowledge manifold of a domain. Change the ontology, change the domain. The engine is the same. The problem class is the same: high stakes, sparse data, ambiguity, irreversible consequences.

Revelio · Appero · Designio
4
Master agents with dynamic sub-agent generation
T/I/F
Neutrosophic epistemic output — not a scalar
RWE
Regulatory-grade evidence as primary output
ACTECON
Compliance partner — at the table from day one
The Substrate
RWE is not a healthcare concept.
It is the compliance layer
every regulated industry runs on.

Real-world evidence is the standard of proof that regulators, underwriters, and clinical governance bodies require before a high-stakes decision can be defended. Standard AI cannot produce it — not because of data volume, but because statistical extrapolation from historical distributions is not causal evidence. ONE.RING produces one thing: RWE-grade causal evidence with explicit epistemic scoring. Every industry below draws from the same output for a different purpose.

Pharma R&D
Trial design and regulatory submission65% of FDA rejections: flawed study design, inadequate patient selection evidence. ONE.RING produces the causal evidence structure submissions require — by design, not by retrofit.
Insurance
Risk compliance and fraud evidenceRegulatory and judicial scrutiny increasingly demands causal evidence of risk assessment basis. Correlation scoring fails under audit. ONE.RING produces causal risk evidence — defensible, not probabilistic.
Clinical
Precision medicine and diagnostic governanceClinical governance mandates individual-level causal reasoning. Population-average inference applied to individual patients is a compliance failure, not an approximation.
The Industry's Blind Spot
Asking for more data
is not a solution.
It is an excuse.

For over a decade, the AI industry's response to failure in high-stakes, sparse-data regimes has been consistent: more data, more labels, larger training sets, more compute. ONE.RING was built on a different diagnosis. The data was never the problem. The objective function was wrong. Statistical models optimised for prediction accuracy cannot produce causal evidence, regardless of how much data they are trained on. More of the same input does not change the structural output limitation.

The knowledge required to reason about a rare disease patient, a novel risk profile, or a complex regulatory decision already exists — in governing equations, clinical ontologies, and causal structures that are partially known. ONE.RING operates on that knowledge. It does not wait for more data. It reasons from what is already understood about how the domain behaves.

The operational distinction
Data-centric AI

Learns statistical associations. Performance bounded by training distribution. Cannot reason outside observed patterns. Knowledge implicit in weight matrices — uninterpretable, unauditable, inadmissible as regulatory evidence.

ONE.RING

Operates on the domain knowledge manifold. Governing equations constrain the solution space. Can reason about cases never previously observed. Knowledge is explicit, structured, auditable — a prerequisite for regulatory compliance.

When data is sparse

Performance degrades. Model confidence is unreliable. Distribution shifts cause silent failure. The model does not know what it does not know — and cannot report it.

When data is sparse

Loki generates physics-constrained synthetic reality from 25% seed data. Hopfield Attractors retrieve the nearest known causal archetype. Indeterminacy is reported explicitly — not suppressed into a scalar confidence score.

Three Structural Failures of Standard AI

Not performance gaps.
Architectural impossibilities.

These are not problems that scale, fine-tuning, or prompt engineering solve. They are consequences of the objective function. Identifying them precisely is the precondition for designing an architecture that does not share them.

01 — OBJECTIVE FUNCTION
Optimised for prediction accuracy. Not for causal evidence.
Minimising prediction error on training data produces accurate interpolation within the distribution. It does not produce causal evidence of mechanism. Regulators require the latter. Statistical AI produces the former — and the gap is not closable by scaling.
Regulatory consequence: scalar probability outputs are not admissible as evidence of causal mechanism for FDA/EMA or equivalent bodies.
02 — DISTRIBUTION BOUNDARY
Silent failure precisely where precision matters most.
Rare disease patients, novel risk profiles, and minority mechanism groups sit outside training distributions. Statistical models extrapolate in these regimes with no signal of their own epistemic limits. The model does not know what it does not know — and cannot tell you. In regulated contexts, this is not an approximation. It is inadmissible.
Regulatory consequence: indeterminate evidence must be explicitly reported. Scalar confidence scores cannot represent what is structurally unknown.
03 — STATIC KNOWLEDGE
Cannot accumulate causal knowledge without full retraining.
Standard architectures update only through backpropagation on labelled data. They cannot integrate new causal knowledge from individual case trajectories, recalibrate reasoning pathway trust from outcomes, or grow a structured knowledge base — without complete retraining on an expanded labelled dataset.
Regulatory consequence: longitudinal evidence accumulation for post-approval surveillance is architecturally impossible in standard ML.
Healthcare
$1T+
Annual US cost from misdiagnosis and diagnostic delay. Rare disease alone: $449B in direct expenditure.
Insurance
$80B+
Annual US losses to fraud and waste. Distribution-shift failures post-COVID exposed the limits of correlation-based models.
Pharma R&D
$2.6B
Average cost per approved drug. 65% of FDA rejections: flawed study design and inadequate patient selection evidence.
Architecture v10.2.1

Four master agents capable of
generating and dissolving specialists on demand.

This is not a fixed ensemble of four models. Each master agent is a sovereign reasoning system. Thoth dynamically generates and dissolves specialist sub-agents as the specific problem demands. The ensemble that processes a rare paediatric enzyme disorder is architecturally different from the one that processes a post-COVID actuarial risk profile — neither was pre-programmed. The system self-optimises continuously, with human input incorporated at the meta-orchestration level.

Four masters. Unlimited specialists.
Assembled per problem. Never pre-programmed.

The four master agents define the permanent reasoning architecture. What operates between them at any decision instance is assembled dynamically by Thoth from the specific problem's requirements. The architecture is generative. It does not select from a fixed menu of configurations — it constructs the configuration the problem requires and dissolves it when the decision is complete. No published architecture operates this way.

Self-optimising: Thoth recalibrates agent reliability weights continuously at the individual profile level — without retraining.
Human-in-the-loop: Clinical, actuarial, and regulatory judgement integrates at defined control points. Designed for augmented decisions, not autonomous replacement.
Dynamic GAN structure: Loki as generator. Distributed discriminator across Heimdall, Mimir, and PINN residual. Thoth as meta-orchestrator. The discriminator function is distributed — no published GAN architecture does this.
PINN residual as scientific finding: A large PINN residual is not a failure signal. It is a scientific finding — the governing equation is incorrectly specified for this population, or the data contains a genuine anomaly theory does not yet account for.
Heimdall
Knowledge Sovereign
Governs the dynamic causal knowledge graph. Activates the case-specific ontology via the Scene Manager before any simulation begins — the ontological gateway of the system. Nothing is computed without Heimdall establishing what is known about this specific case. Accumulates causal knowledge as structured ontology, not parameter drift. The ontology is swappable — change it and the entire system reasons in a new domain.
Ontology swap = domain swap. The knowledge layer is the customisation surface for the entire architecture.
Loki
Physics Engine
Generates physics-constrained synthetic cohorts via Kolmogorov-Arnold Networks (KANs) and Physics-Informed Neural Networks (PINNs). KANs preserve the multi-scale signal structure that encodes biological, actuarial, and behavioural mechanism — MLPs smooth over it. Hopfield Attractor states enable pattern completion from partial or sparse inputs: Loki does not fail when data is incomplete, it retrieves the nearest known causal archetype. The Neural Key Chain compounds with every case processed — the architecture becomes more capable with use, not less.
Synthetic cohorts are simultaneously retrospective and prospective. They can simulate trajectories that have never been observed — because they are constrained by governing equations, not historical distributions.
Thoth
Meta-Optimiser and Orchestrator
Orchestrates the full ensemble. Dynamically spawns and dissolves specialist sub-agents via the Solution Blueprint — the generative core of the architecture's adaptability. Recalibrates agent reliability weights at the individual case profile level. Operates a composite variational free-energy loss function — formally identified as such. Designed consistent with Lyapunov stability conditions; formal analytical characterisation in preparation. T25 is a module within Thoth.
Different cases receive different agent trust configurations. The orchestration layer is not static — it is a continuously recalibrating meta-intelligence.
Mimir
Adjudicator
Performs competitive hypothesis fusion via neutrosophic aggregation. A second RAG instance within Mimir grounds sub-agent reasoning in structured knowledge during fusion. Produces the T/I/F output: Truth, Indeterminacy, Falsity — three-dimensional epistemic state, not a scalar confidence score. The I-component maps directly to what evidence is missing, making uncertainty actionable for regulators and decision-makers rather than hidden inside a probability.
Indeterminacy is a first-class output. Reporting what is not known is a regulatory compliance requirement — not a weakness to be hidden.
Three simultaneous non-backpropagated learning mechanisms — all operate in parallel at all times
Thoth RL Meta-Learning
Alpha-j reliability weights recalibrate per agent at the individual profile level. Different cases receive different trust configurations based on observed outcomes. The system learns which agents to trust for which problem types — without retraining the underlying networks.
Heimdall Knowledge Graph Updates
New causal relationships integrate as structured ontology via directed graph extension. Knowledge accumulates permanently and is not washed out by subsequent cases. The knowledge base grows; the parameters do not drift.
Loki Neural Key Chain Accumulation
KAN spline parameters, Hopfield Attractor states, and causal similarity retrieval compound with every case. A partner who has processed 100 cases has a measurably more capable physics engine than one who has processed 10. Advantage accretes with use.
Customisable by Ontology

Change the ontology.
Change the domain.
The engine is the same.

ONE.RING is not built for pharma, or insurance, or clinical medicine specifically. It is built for a class of problems — high-stakes decisions under complexity and ambiguity, where data is sparse, mechanisms are partially known, and the cost of being wrong is irreversible. Heimdall's ontology layer is the customisation surface. Load a clinical Phen-Gen ontology and the system reasons about rare disease. Load an actuarial constraint ontology and it reasons about insurance risk. Load a regulatory compliance ontology and it reasons about policy ambiguity.

The PINN layer follows the same principle. Governing equations are domain-specific but the constraint enforcement mechanism is universal. Any domain with formalisable governing relationships — biological, actuarial, behavioural, physical, social — can be incorporated as a PINN constraint layer without modifying the core architecture.

This is not configurability in the software sense. It is domain-invariance at the architectural level. The knowledge layer and the constraint layer are the only things that change between domains. Everything else — the four master agents, the neutrosophic aggregation, the RWE compliance output — remains constant.

Fixed Layer
Four Master Agents + Neutrosophic Engine Constant
Fixed Layer
RWE Compliance Output (T/I/F) Constant
Swap Layer
Heimdall Ontology Domain-specific
Swap Layer
Loki PINN Governing Equations Domain-specific
Result
New domain. Same engine. Same output standard.
The Phen-Gen profile is the clinical instance of this principle: patient-specific phenotypic-genomic ontology loaded per individual, not per population. Precision medicine is ontology-swap at the individual patient level.
One Outcome — Different Industry Uses

The compliance chain produces one thing.
Every industry draws from it differently.

T/I/F-scored RWE-grade causal evidence is a single architectural output. Pharma uses it for regulatory submission. Insurance uses it for risk defence. Clinical medicine uses it for precision treatment governance. Government and complex systems use it for policy evidence under ambiguity. The substrate does not change. The surface does.

Stage 01
Heimdall Scene Manager
Activates case-specific ontology. The precision medicine act — establishing what is known about this individual, this risk, this policy question before any computation begins.
Stage 02
Loki PINNs
Case-specific governing equations. Enzyme kinetics, PK/PD, actuarial constraints, behavioural equations — calibrated to this case, not population averages.
Stage 03
Neutrosophy Loop
T/I/F evidence quality tracked at every iteration. Indeterminacy accumulates as a first-class signal — not suppressed into a scalar score.
Stage 04
T/I/F Dashboard
Real-time three-dimensional epistemic display. What evidence supports, what is unknown, what it argues against — for this specific case.
Stage 05
Logic Replay Buffer
Complete T/I/F evolution as RWE compliance instrument. Audit trail of how evidence developed, what gaps exist, what would resolve them. Not a log file — a regulatory evidence record.
Stage 06
RWE Output
T/I/F-scored evidence to FDA/EMA or equivalent regulatory body. I-component maps explicitly to actionable evidence gaps. Regulatory-grade by design, not by post-hoc documentation.
Pharma R&D
Causal evidence for trial design and regulatory submission
The same RWE output that satisfies FDA/EMA evidentiary standards guides patient selection, study design, and mechanism identification. The compliance requirement and the scientific requirement are the same problem — solved once.
  • Synthetic cohort generation from 25% real-world seed
  • Target trial emulation with RWE-grade output
  • Rare disease mechanism identification in sparse regimes
  • PK/PD-calibrated precision dosing simulation
Insurance and Risk
Defensible causal evidence of risk — not correlation
Regulatory and judicial scrutiny increasingly demands causal evidence of the basis for risk decisions. Actuarial tables derived from historical correlation are exposed under adverse selection, distribution shift, and fraud litigation.
  • Actuarial constraint systems as PINN governing equations
  • T/I/F fraud detection — uncertainty explicit, not hidden
  • Novel product pricing under distribution shift
  • Post-COVID comorbidity risk modelling
Clinical Healthcare
Precision medicine at the individual patient level
Precision medicine is a governance standard. Population-level inference applied to individual patients is a compliance failure mode. ONE.RING's architecture was designed from this constraint — individual case ontology, individual case governing equations, individual case RWE output.
  • Phen-Gen profile calibration per individual
  • T/I/F epistemic display for clinical governance
  • RWE compliance trail for post-approval surveillance
  • Rare disease diagnostic support in sparse phenotypic data
Beyond Regulated Industries

Any domain with complexity, ambiguity,
and irreversible consequences.

ONE.RING was described by one reviewer as a government-level architecture for ambiguity and complexity. That is accurate. The same class of problem that breaks statistical AI in pharma and insurance — high stakes, sparse data, partially known mechanisms, asymmetric cost of error — exists across multiple domains that have never had an architecture capable of producing RWE-grade causal evidence. The ontology swap is the only thing required to address them.

Government and Policy
Policy evidence under systemic ambiguity
Policy decisions operate on complex causal systems with sparse observational data, lagged consequences, and adversarial information environments. The evidentiary standard for major policy decisions — what changed, why, with what epistemic confidence — is exactly the RWE problem ONE.RING was built to solve. Load a governance ontology. The engine reasons over policy intervention spaces the same way it reasons over clinical ones.
Defence and Intelligence
Causal inference under adversarial sparse data
Intelligence assessments operate under deliberately sparse, noisy, and adversarially corrupted data. Standard probabilistic models are exploitable precisely because they extrapolate from distributions — distributions that adversaries can manipulate. A knowledge-based causal architecture with explicit indeterminacy reporting produces assessments that are honest about what is not known, which is the correct epistemic posture in adversarial environments.
Environmental and Climate Compliance
Causal evidence for regulatory environmental decision-making
Environmental compliance and climate adaptation decisions require causal evidence of intervention effects in complex systems with sparse monitoring data and long causal chains. The PINN layer can incorporate physical, ecological, and economic governing equations simultaneously. Regulatory bodies increasingly require causal evidence of environmental impact — not statistical correlation.
Financial Systemic Risk
Causal chain analysis beyond correlation
Systemic financial risk analysis requires understanding causal transmission chains — how a shock in one node propagates through a network. Correlation-based models cannot distinguish causal transmission from coincident movement. Regulators require the former. ONE.RING's architecture, with a financial systems ontology and appropriate governing equations, produces the causal evidence that stress-testing and systemic risk assessment demand.
Legal and Regulatory Adjudication
Precedent as ontology — ambiguity as structural feature
Legal reasoning operates on structured ontologies (precedent, statute, jurisdiction) applied to novel fact patterns — a domain where ambiguity is not a defect but a structural feature of the task. The T/I/F output is precisely suited to legal epistemic requirements: what the evidence supports, what is contested, and what it argues against — reported with explicit epistemic accountability.
Your Domain
High stakes. Sparse data. Ambiguity. Irreversible consequences.
If your domain has formalisable governing relationships, a structured ontology that can be loaded into Heimdall, and decisions where the cost of silent model failure is unacceptable — ONE.RING's architecture is applicable. The customisation requirement is ontology and governing equations. The RWE-grade causal evidence output is the same regardless of domain.

"The problem is not the industry. It is the class of problem — ambiguity, complexity, sparse data, irreversible stakes. Change the ontology. The engine already knows how to reason about it."

Why Take This Seriously

An independent R&D startup with a compliance partner at the table from day one.

Most AI companies build a model, then ask what it is for. ONE.RING was built backwards: from the regulatory and clinical compliance requirement, inward to the architecture. ACTECON's presence as compliance partner is evidence of that sequence. We know the industries we operate in. We walk the talk.

Compliance Partnership

ACTECON

ACTECON operates as compliance partner to Data Beasts FZCO. Their engagement at pre-deployment stage signals that the architecture is being built to the evidentiary and regulatory standards it will ultimately need to satisfy — not patched for compliance after proof of concept. This is not a commercial arrangement. It is an architectural commitment.

We are not a research project that has discovered an industry application. We are a compliance-forward architecture that has identified the industries where the problem is most acute.

AC
ACTECON
Compliance Partner — Data Beasts FZCO
Architecture Positioning

Where ONE.RING sits in the landscape

Entries below reflect architectural design properties and published literature as of early 2026. Entries marked as limited reflect active field development. ONE.RING entries are architectural — empirical benchmarking at scale requires POC.

CapabilityLLMsAutoMLONE.RING
Causal inferenceLimited Architectural
Sparse data regimes PINN simulation
Epistemic T/I/F output Neutrosophic
RWE compliance output Logic Replay Buffer
Non-backpropagated learning Three mechanisms
Dynamic sub-agent generation Thoth orchestration
Ontology-driven customisation Heimdall layer

Pre-deployment. No clinical accuracy claim is made. POC validation required at production scale.

About

Data Beasts FZCO

An independent R&D startup based in Dubai, UAE. ONE.RING was built from a specific observation: the regulatory and clinical evidence requirements that govern high-stakes decisions in pharma, insurance, and clinical medicine cannot be satisfied by statistical AI — not by scaling it, not by fine-tuning it, not by prompting it differently. The objective function is wrong. That required a different architecture, not a better version of the same one.

We are at pre-deployment stage. The architecture is built, the compliance partner is engaged, and the documentation is at technical white paper standard. We are actively seeking seed-stage co-investment, strategic partnerships, and academic collaboration from parties who understand the problem this architecture is designed to solve — and have been told for too long that more data will fix it.

EntityData Beasts FZCO, Dubai UAE
StageIndependent R&D startup — pre-deployment. Seeking seed-stage investment, strategic co-operation, and academic collaboration.
ComplianceACTECON — active compliance partner from pre-deployment stage
FrameworkArchitecture Flow v10.2.1 | Technical White Paper v7.1.3
StatusAll discussions hypothetical and pre-deployment. No clinical, diagnostic, or regulatory claims made.
Dr. Yusuf Fikret UMUR
Co-Founder — Architecture and IP
Suat Lemi Sisik
Co-Founder
Contact
"Reveal the structure of the problem before designing the solution."
Engage

We are looking for the right partners. Not the most partners.

ONE.RING is pre-deployment. We engage with pharma R&D organisations, insurance and risk bodies, clinical research institutions, government and policy bodies, and academic collaborators who are working directly on the structural problems this architecture addresses.

If you have been told that more data will solve the problem — and you are beginning to suspect that it will not — that is the conversation we want to have.

Pharma R&D Insurance Clinical Research Government Academic Collaboration Seed Investment Strategic Co-operation
LocationDubai, United Arab Emirates

Enquiry

All enquiries are confidential. NDA available on request. We respond to serious institutional and investment enquiries within 5 working days.